Biostrap

Biofourmis is a rapidly growing digital therapeutics company that is the leader in Personalized Predictive Care. Our disruptive innovations use advanced clinical-grade wearable sensors to continuously monitor bio vitals and process them using our patented and FDA-approved AI/ML algorithms to predict changes in physiology that are co-related to medical and disease events in the cardiac, oncology, respiratory, and other therapeutic areas.

We are pioneering an entirely new category of the healthcare system, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.

We are a dynamic high-growth company, having quadrupled in size in the last 12 months. We are a Global organization with offices in Boston, Singapore, and Bangalore. We are backed by some of the premier venture capitalists in the world and enjoy the confidence of customers who are leaders in the healthcare and life sciences industry.

Dozee is India’s 1st AI-based contactless Remote Patient Monitoring (RPM) & Early Warning System (EWS) for continuous patient monitoring with a mission to develop & deploy intelligent technologies, solutions, and networks to provide a continuum of care, early warning systems, and responses to save lives.

Supported by the Government of India through BIRAC, Dozee is on a path to steer the trajectory of the public and private healthcare ecosystem. With the aim of providing connected health in every bed, Dozee strives to improve access and put patient care first with its vision of #HarBedDozeeBed. Dozee tracks vital parameters such as the Heart Rate, Respiratory Rate, Blood Pressure, Blood Oxygen Saturation, and Skin Temperature with clinical grade accuracy, and tracks sleep quality while flagging indicators of sleep apnea.

Dozee continues to reimagine health and create a future where healthcare is smarter and connected.